Sorted By:

Relevance


Medicines in Development for Neurological Disorders 2015 Report

PhRMA  |  Report

Learn more in the Medicines in Development report
https://www.phrma.org/report/medicines-in-development-for-neurological-disorders-2015-report

Medicare Monday: Resources for understanding Medicare Part B and D

PhRMA  |  Blog Post

Below are a few of the resources included in the chart pack: Medicare Covers Two Benefits Medicare’s retail pharmacy benefit is called Part D, and Medicare’s medical benefit is called Part B.
http://catalyst.phrma.org/medicare-monday-resources-for-understanding-medicare-part-b-and-d

4 Things to know about the QuintilesIMS Medicines Use and Spending in the U.S. report

PhRMA  |  Blog Post

Here are four things you should know about the latest QuintilesIMS report: After accounting for discounts and rebates, spending on medicines grew just 4.8 percent in 2016.
http://catalyst.phrma.org/4-things-to-know-about-the-quintilesims-medicines-use-and-spending-in-the-us-report

PhRMA Statement on 2015 Special 301 Report

PhRMA  |  Press Release

PhRMA members appreciate the prominent mention of these concerns in the Special 301 Report.
https://www.phrma.org/press-release/phrma-statement-on-2015-special-301-report

US Biopharmaceutical Exports Have Grown

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-7/us-biopharmaceutical-exports-have-grown

Ask About Adherence: New resources from The Medication Adherence Alliance

PhRMA  |  Blog Post

Visit managingyourmeds.org to check out all of the resources.
http://catalyst.phrma.org/ask-about-adherence-new-resources-from-the-medication-adherence-alliance

Programs and Initiatives

PhRMA  |  From PhRMA

Biopharmaceutical research and clinical trials are taking place across the U.S. every day. Explore the interactive map below and select a state to access data on biopharmaceutical jobs, the industry's overall economic impact, clinical trial activity, and more. ...
https://www.phrma.org/resources/state-map/stem

New Report Shows More than 240 Immuno-Oncology Treatments in Development for Patients with Cancer

PhRMA  |  Press Release

The full “Medicines in Development for Immuno-Oncology” report can be downloaded here.
https://www.phrma.org/press-release/new-report-shows-more-than-240-immuno-oncology-treatments-in-development-for-patients-with-cancer

PhRMA Launches New Spanish-Language Health Care Resources

PhRMA  |  Press Release

For more resources, visit AccessBetterCoverage.org/espanol. 
https://www.phrma.org/press-release/phrma-launches-new-spanish-language-health-care-resources

How to Get Payment Reforms Right

Access Better Coverage  |  From Our Network

 Reforms should be based on the best clinical evidence.
http://www.accessbettercoverage.org/social-news/how-to-get-payment-reforms-right

ITIF report shows how Canada’s IP system is falling behind

PhRMA  |  Blog Post

As the report states, “Without sufficient IP protections, innovators will have little motivation to invest the economic resources necessary to discover new pharmaceutical compounds.
http://catalyst.phrma.org/itif-report-shows-how-canadas-ip-system-is-falling-behind

PhRMA Statement on 2016 Special 301 Report

PhRMA  |  Press Release

PhRMA members welcome USTR’s decision to maintain India on the Priority Watch List and the emphasis the Special 301 Report places on achieving substantive and measurable results.
https://www.phrma.org/press-release/phrma-statement-on-2016-special-301-report

US Biopharmaceutical Exports Have Grown

Chartpack  |  From Our Network

Biopharmaceutical exports have nearly tripled over the 13-year period between 2002 and 2014.
http://chartpack.phrma.org/biophrma-chartpack/economic-impact/us-biopharmaceutical-exports-have-grown

PhRMA Reports 836 Medicines and Vaccines in Development to Treat Cancer

PhRMA  |  Press Release

View the full reportView the medicine list   About The Pharmaceutical Research and Manufacturers of America (PhRMA) The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-reports-836-medicines-and-vaccines-in-development-to-treat-cancer

New Report: Clinical Trials and the Impact on State Economies

PhRMA  |  Blog Post

This report’s focus is solely on investments made at clinical trial sites, and doesn’t capture all of the trial-wide work that occurs across sites, which includes things like trial design, coordination, and data analysis, nor does it capture the substantial investments companies make every year in basic and preclinical research, before projects ever get to the clinical testing phase.
http://catalyst.phrma.org/new-report-clinical-trials-and-the-impact-on-state-economies

Medicines in Development for Women 2013 Report

PhRMA  |  Report

In separate reports, PhRMA has found that researchers are working on 299 medicines for heart disease and stroke, which kill nearly a half-million women each year, and 98 medicines for lung cancer, the leading cancer killer of women (see page 60 for details).
https://www.phrma.org/report/medicines-in-development-for-women

Economic Impact

PhRMA  |  From PhRMA

Biopharmaceutical research and clinical trials are taking place across the U.S. every day. Explore the interactive map below and select a state to access data on biopharmaceutical jobs, the industry's overall economic impact, clinical trial activity, and more. ...
https://www.phrma.org/resources/state-map

PhRMA Applauds Innovation, Access Policies in US-Japan Report

PhRMA  |  Press Release

Government and the Government of Japan and hope that any future reforms will continue to move in this direction.”
https://www.phrma.org/press-release/phrma-applauds-innovation-access-policies-in-us-japan-report

PhRMA Statement on AARP Report

PhRMA  |  Press Release

“The prices for the ‘top 25’ drugs highlighted in the last AARP report fell by 21 percent from 2006 through 2009, according to researchers at IMS Health and MIT.
https://www.phrma.org/press-release/phrma-statement-on-aarp-report1

Medicines in Development for Vaccines 2017 Update

PhRMA  |  Report

Download the report to learn more.
https://www.phrma.org/vaccines-2017-report

The Biopharmaceutical Pipeline

PhRMA  |  Report

Download the Executive Summary Download the Full Report
https://www.phrma.org/report/the-biopharmaceutical-pipeline

The Value Collaborative

PhRMA  |  From PhRMA

View reports, comment letters, fact sheets and codes and guidelines explaining policy and regulatory changes that can help advance value-driven health care.
https://www.phrma.org

Economic Impact Report

PhRMA  |  Report

At a time when the economic competitiveness at the national and state level is recognized to be strongly rooted in the capacity to advance innovation-based industries, the U.S. biopharmaceutical industry stands out as a leading research and development (R&D) and advanced manufacturing industr...
https://www.phrma.org/report/economic-impact-report

PhRMA Principles for Payment and Delivery System Reforms

PhRMA  |  Codes & Guidelines

Report to Congress, Medicare and the Health Care Delivery System.”
https://www.phrma.org/codes-and-guidelines/phrma-principles-for-payment-and-delivery-system-reforms

2010 Report Medicines in Development: Children

PhRMA  |  Report

Biopharmaceutical researchers are testing 234 medicines to meet the special health needs of children. These medicines offer hope that the significant improvements achieved in children’s health over the past few decades will continue and even accelerate. The potential medicines are either in clini...
https://www.phrma.org/report/2010-report-medicines-in-development-children

You have reviewed the first 75 results out of 1009. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next